8700
Evaluating the Feasibility and Acceptability of Goal Attainment Scaling in Heterogeneous Alzheimer’s Disease Populations
Gunes Sevinc, Lois Kelly, Hampus Hillerstorm, James Hendrix, Arlene Kelly-Wiggins, Chere Chapman, Kenneth Rockwood
Eli Lilly and Company, Ardea Outcomes, Dalhousie University, National Down Syndrome Society, Nova Scotia Health Authority
Poster Presenter: Chere Chapman
